HIK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hikma Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 1 600 GBX 0.25% Market Closed

Market Cap: £3.4B

	Hikma Pharmaceuticals PLC LSE:HIK	UK
	Mitsubishi Chemical Holdings Corp TSE:4188	JP
K	Komatsu Ltd XMUN:KOM1	JP
P	Pfizer Inc BMV:PFE	US
	Siemens AG OTC:SIEGY	DE
	Airports of Thailand PCL OTC:ARPRF	TH
	Consolidated Water Co Ltd NASDAQ:CWCO	KY
U	Unity Software Inc F:US3	US
A	Autozone Inc SWB:AZ5	US
	Kumba Iron Ore Ltd OTC:KIROY	ZA
	Vcplus Ltd SGX:43E	MY
C	CMOC Group Ltd XMUN:D7N	CN
P	Pfizer Inc F:PFE	US

Profitability Summary

Hikma Pharmaceuticals PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

44%

Sustainable 3Y Average Gross Margin

46%

Declining Gross Margin

50% > 44%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

21%

Declining Operating Margin

23% > 21%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

5% > 14%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

14% > 6%

Positive ROE

18%

Positive 3Y Average ROE

Positive 3Y Average ROIC

12%

ROIC is Increasing

10% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.